Dennis Mulroy insider trades

Open-market stock purchases and sales by Dennis Mulroy, Chief Financial Officer at Arcturus Therapeutics Holdings Inc, from SEC Form 4 filings since Feb 28, 2014.

Recent trades

DateStockTradeValue
May 1, 2026ARCT Arcturus Therapeutics Holdings IncBought (not open market)—
Jan 8, 2026ANAB Anaptysbio, IncSold$112K
Jan 7, 2026ANAB Anaptysbio, IncSold$86.1K
Jan 7, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 6, 2026ANAB Anaptysbio, IncBought (not open market)—
Jan 5, 2026ANAB Anaptysbio, IncSold$145K
Jan 3, 2026ANAB Anaptysbio, IncBought (not open market)—
Dec 22, 2025ANAB Anaptysbio, IncSold$500K
Dec 22, 2025ANAB Anaptysbio, IncBought (not open market)—
Dec 16, 2025ANAB Anaptysbio, IncBought (not open market)—
Dec 16, 2025ANAB Anaptysbio, IncSold$418K
Dec 16, 2025ANAB Anaptysbio, IncSold$288K

Companies traded

  • ARCT Arcturus Therapeutics Holdings Inc: other filings, last May 1, 2026
  • ANAB Anaptysbio, Inc: 13 sales, last Jan 8, 2026
  • LJPC LA Jolla Pharmaceutical Co: 1 buy, last May 29, 2020
  • CRXM Cardium Therapeutics, Inc: other filings, last Feb 28, 2014

Get free alerts when Dennis Mulroy files a new trade →